Article ID Journal Published Year Pages File Type
9145529 Cardiovascular Revascularization Medicine 2005 7 Pages PDF
Abstract
In our experience, the C stent is superior to the T stent when treating populations with a high percentage of complex lesions excluded from the trials.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Medicine
Preview
Clinical and angiographic follow-up in patients with Cypher or Taxus stents in populations with high percentage of trial-excluded lesions
Authors
, , , , , ,